Literature DB >> 725521

Evaluation of methaemalbumin in acute pancreatitis.

P G Lankisch, H Koop, J Otto, U Oberdieck.   

Abstract

Methaemalbumin (MHA) was measured in 62 patients with acute pancreatitis. In 26 MHA-positive patients the occurrence of renal and pulmonary complications was 65% and 58%, respectively, compared with 3% and 6% in 36 MHA-negative patients. Fatality rate was 54% in MHA-positive and 6% in MHA-negative patients. In 17 MHA-positive cases haemorrhagic pancreatitis was proven at laparotomy or postmortem examination. Thus MHA determination proved to be a valuable diagnostic and prognostic parameter in acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 725521     DOI: 10.3109/00365527809181378

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Intensive medical treatment of severe acute pancreatitis.

Authors:  W Creutzfeldt; P G Lankisch
Journal:  World J Surg       Date:  1981-05       Impact factor: 3.352

2.  Percutaneous peritoneal dialysis as an early treatment of acute necrotic hemorrhagic pancreatitis.

Authors:  M S Reynaert; Z H Bshouty; J B Otte; P J Kestens; J Tremouroux
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

Review 3.  Early assessment of severity in acute pancreatitis.

Authors:  R C Williamson
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

4.  Correlation of pancreatic enzyme levels with the patient's recovery from acute edematous pancreatitis.

Authors:  P G Lankisch; H Buschmann-Kaspari; J Otto; K Schröder; H Koop
Journal:  Klin Wochenschr       Date:  1990-06-05

5.  Methaemalbumin formation in sickle cell disease: effect on oxidative protein modification and HO-1 induction.

Authors:  Madelyn S Hanson; Barbora Piknova; Agnes Keszler; Anne R Diers; Xunde Wang; Mark T Gladwin; Cheryl A Hillery; Neil Hogg
Journal:  Br J Haematol       Date:  2011-05-20       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.